HeartBeam
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 15
- Market Cap
- -
- Introduction
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.
Clinical Trials
1
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
AIMIGo 12L ECG Synthesis Software Pivotal Study for Arrythmia Detection
- Conditions
- Arrhythmias, CardiacTachycardiaAtrial FlutterBradycardiaAtrial Fibrillation
- First Posted Date
- 2023-11-08
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- HeartBeam, Inc.
- Target Recruit Count
- 198
- Registration Number
- NCT06123130
- Locations
- 🇺🇸
Piedmont Heart Institute, Atlanta, Georgia, United States
🇺🇸Atlanta Heart Specialists, Tucker, Georgia, United States
🇺🇸The Mount Sinai Hospital, New York, New York, United States
News
HeartBeam Submits FDA Application for 12-Lead ECG Synthesis Software
HeartBeam has submitted a 510(k) application to the FDA for its 12-lead ECG synthesis software, designed to assess various cardiac rhythms and arrhythmias.